Duncker Streett & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $141K | Hold |
1,960
| – | – | 0.03% | 257 |
|
|
2025
Q4 | $156K | Hold |
1,960
| – | – | 0.03% | 244 |
|
|
2025
Q3 | $148K | Sell |
1,960
-50
| -2% | -$3.43K | 0.03% | 252 |
|
|
2025
Q2 | $139K | Hold |
2,010
| – | – | 0.03% | 253 |
|
|
2025
Q1 | $136K | Sell |
2,010
-100
| -5% | -$5.98K | 0.03% | 249 |
|
|
2024
Q4 | $94.7K | Sell |
2,110
-1,325
| -39% | -$74.3K | 0.02% | 273 |
|
|
2024
Q3 | $216K | Sell |
3,435
-4,756
| -58% | -$277K | 0.04% | 225 |
|
|
2024
Q2 | $484K | Sell |
8,191
-7,257
| -47% | -$454K | 0.09% | 154 |
|
|
2024
Q1 | $1.23M | Sell |
15,448
-2,425
| -14% | -$185K | 0.24% | 95 |
|
|
2023
Q4 | $1.41M | Sell |
17,873
-100
| -0.6% | -$7.12K | 0.3% | 89 |
|
|
2023
Q3 | $1.25M | Sell |
17,973
-300
| -2% | -$21.3K | 0.29% | 90 |
|
|
2023
Q2 | $1.26M | Hold |
18,273
| – | – | 0.28% | 91 |
|
|
2023
Q1 | $1.36M | Sell |
18,273
-2,131
| -10% | -$179K | 0.32% | 83 |
|
|
2022
Q4 | $1.9M | Hold |
20,404
| – | – | 0.46% | 62 |
|
|
2022
Q3 | $1.95M | Sell |
20,404
-70
| -0.3% | -$6.93K | 0.5% | 59 |
|
|
2022
Q2 | $1.9M | Sell |
20,474
-1,175
| -5% | -$115K | 0.45% | 66 |
|
|
2022
Q1 | $2.19M | Sell |
21,649
-610
| -3% | -$64.1K | 0.44% | 72 |
|
|
2021
Q4 | $2.3M | Buy |
22,259
+406
| +2% | +$37.5K | 0.4% | 82 |
|
|
2021
Q3 | $1.85M | Sell |
21,853
-2,100
| -9% | -$176K | 0.35% | 93 |
|
|
2021
Q2 | $2M | Sell |
23,953
-4,114
| -15% | -$337K | 0.37% | 89 |
|
|
2021
Q1 | $2.11M | Sell |
28,067
-905
| -3% | -$65.9K | 0.4% | 83 |
|
|
2020
Q4 | $1.98M | Sell |
28,972
-2,481
| -8% | -$161K | 0.38% | 82 |
|
|
2020
Q3 | $1.84M | Sell |
31,453
-10,168
| -24% | -$633K | 0.4% | 81 |
|
|
2020
Q2 | $2.7M | Sell |
41,621
-19,203
| -32% | -$1.21M | 0.64% | 50 |
|
|
2020
Q1 | $3.61M | Sell |
60,824
-3,139
| -5% | -$210K | 0.96% | 24 |
|
|
2019
Q4 | $4.75M | Buy |
63,963
+1,039
| +2% | +$73K | 1% | 17 |
|
|
2019
Q3 | $3.97M | Buy |
62,924
+2,873
| +5% | +$170K | 0.92% | 29 |
|
|
2019
Q2 | $3.27M | Buy |
60,051
+8,531
| +17% | +$459K | 0.73% | 41 |
|
|
2019
Q1 | $2.78M | Buy |
51,520
+4,479
| +10% | +$276K | 0.64% | 46 |
|
|
2018
Q4 | $3.08M | Buy |
47,041
+3,191
| +7% | +$238K | 0.83% | 31 |
|
|
2018
Q3 | $3.45M | Buy |
43,850
+2,527
| +6% | +$181K | 0.78% | 31 |
|
|
2018
Q2 | $2.66M | Buy |
41,323
+2,012
| +5% | +$133K | 0.66% | 45 |
|
|
2018
Q1 | $2.45M | Hold |
39,311
| – | – | 0.62% | 44 |
|
|
2017
Q4 | $2.85M | Buy |
39,311
+7,726
| +24% | +$562K | 0.73% | 34 |
|
|
2017
Q3 | $2.57M | Buy |
31,585
+781
| +3% | +$61.8K | 0.78% | 35 |
|
|
2017
Q2 | $2.48M | Sell |
30,804
-77
| -0.2% | -$6.08K | 0.77% | 35 |
|
|
2017
Q1 | $2.42M | Buy |
30,881
+570
| +2% | +$45.5K | 0.76% | 35 |
|
|
2016
Q4 | $2.39M | Sell |
30,311
-1,073
| -3% | -$86.8K | 0.8% | 34 |
|
|
2016
Q3 | $2.79M | Buy |
31,384
+1,153
| +4% | +$109K | 0.97% | 24 |
|
|
2016
Q2 | $2.9M | Sell |
30,231
-97
| -0.3% | -$9.67K | 1.03% | 25 |
|
|
2016
Q1 | $3.15M | Buy |
30,328
+738
| +2% | +$71.8K | 1.16% | 15 |
|
|
2015
Q4 | $2.89M | Sell |
29,590
-150
| -0.5% | -$14.7K | 1.08% | 20 |
|
|
2015
Q3 | $2.87M | Buy |
29,740
+100
| +0.3% | +$10.5K | 1.12% | 17 |
|
|
2015
Q2 | $3.11M | Sell |
29,640
-2,850
| -9% | -$291K | 1.08% | 16 |
|
|
2015
Q1 | $3.35M | Hold |
32,490
| – | – | 1.1% | 17 |
|
|
2014
Q4 | $3.13M | Hold |
32,490
| – | – | 1.03% | 20 |
|
|
2014
Q3 | $2.59M | Sell |
32,490
-1,633
| -5% | -$129K | 0.88% | 25 |
|
|
2014
Q2 | $2.57M | Buy |
34,123
+2,895
| +9% | +$219K | 0.83% | 24 |
|
|
2014
Q1 | $2.34M | Buy |
31,228
+1,372
| +5% | +$96.9K | 0.83% | 28 |
|
|
2013
Q4 | $2.14M | Buy |
29,856
+4,880
| +20% | +$314K | 0.77% | 32 |
|
|
2013
Q3 | $1.42M | Sell |
24,976
-6,300
| -20% | -$375K | 0.57% | 46 |
|
|
2013
Q2 | $1.79M | Buy |
+31,276
| New | +$1.81M | 0.68% | 39 |
|
Other funds holding CVS
VCM
VPM
Duncker Streett & Co's CVS Position: Q1 2026 in Review
Duncker Streett & Co held its CVS Health (CVS) position steady in Q1 2026 at 1,960 shares worth $141K. The position accounts for 0.03% of the portfolio, ranked #257.
Duncker Streett & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.75M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Duncker Streett & Co held 1,960 shares of CVS Health worth $141K as of Q1 2026.
- Duncker Streett & Co left its CVS Health share count unchanged in Q1 2026.
- CVS Health made up 0.03% of Duncker Streett & Co's portfolio in Q1 2026, its #257 holding.
- Duncker Streett & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Duncker Streett & Co's CVS Health position peaked at $4.75M in Q4 2019.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.